Clinical trials
Growth clinical trials
Below are recruiting growth clinical trials, each written for real people, not researchers. We’re tracking 295 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07075276Recruiting
Comparing a new growth factor treatment to standard care for jaw joint pain
This study tests a new treatment for a common jaw joint problem called disc displacement. It compares a concentrated growth factor from your own blood to standard care to see which helps more with pain and jaw movement.
Damietta, New DamiettaAges 18–45 - NCT07072234RecruitingPhase 1
CAR NK cell therapy for advanced clear cell kidney cancer
This trial tests a new type of immune cell therapy (CAR NK cells) that targets a protein called CD70 on kidney cancer cells. It's for people with advanced clear cell kidney cancer that hasn't responded to standard treatments.
Houston, TexasAges 18 years+ - NCT07025031Recruiting
Fetal growth restriction study comparing cases to controls
This study compares babies with fetal growth restriction (slower growth in the womb) to babies growing normally. It looks for causes and risk factors using medical records and questionnaires. You may join if you are expecting a single baby with a known due date and without certain health conditions or medications.
Kuala Lumpur, Kuala LumpurAges 19 years+ - NCT07029282RecruitingPhase 3
Vitamin supplement study for pregnant women and new moms
This trial tests a special vitamin supplement (MMSPlus) given before and after birth to improve baby growth. Pregnant women with a healthy single baby can join, and then continue after birth if they plan to breastfeed.
Karachi, SindhAges 15–49 - NCT07018362Enrolling by invitation
Ultrasound study of fetal growth in healthy pregnancies
This study uses ultrasound to check how well your baby is growing during pregnancy. It helps doctors understand normal growth patterns so they can better care for you and your baby.
Xiamen, FujianAges 18–45 - NCT05651347RecruitingPhase 3
Melatonin in pregnancy to protect babies with slow growth
This trial studies whether taking melatonin during pregnancy can help protect the baby’s brain and organs in cases of poor fetal growth. It focuses on pregnancies at a specific gestational age with signs that the placenta may not be working well.
Camperdown, New South WalesAges 18 years+ - NCT06975683Recruiting
PRGF ovarian injection for low ovarian reserve
This study tests a special injection of growth factors from your own blood into the ovary to see if it can improve egg quality and quantity for women with low ovarian reserve. It may be an option if you have been trying to conceive for over a year and have low egg reserve.
MadridAges 18–50 - NCT06952998RecruitingPhase 4
Platelet-rich plasma for diabetic foot ulcers with artery disease
This trial tests if a special treatment made from your own blood (platelet-rich plasma) can help heal foot ulcers in people with diabetes and poor circulation in their legs. The goal is to see if it improves wound healing compared to standard care.
Bilbao, BizkaiaAges 18 years+ - NCT06948214RecruitingPhase 3
LUM-201 for growth hormone deficiency in children
This trial tests a new medicine called LUM-201 for children who haven't grown enough because their bodies don't make enough growth hormone. It aims to help kids who haven't been treated before and are still at an early stage of puberty.
Birmingham, AlabamaAges 3–11 - NCT06932614Recruiting
Growth factor vs PRP for knee arthritis
This trial compares two injections—a special growth factor treatment and a platelet-rich plasma (PRP) injection—to see which works better for knee osteoarthritis. It aims to help people with mild to moderate knee arthritis who have had pain for at least 3 months.
TaipeiAges 20–80 - NCT06919757Recruiting
Early Lung Health in Very Premature Infants
This study compares the early lung development of very premature babies who had growth problems in the womb to those who did not. The goal is to understand how growth in the womb affects lung health after birth.
RomaAges Any age - NCT06919692Recruiting
Lying on left side for fetal growth restriction
This study tests if lying on your left side can help improve blood flow and oxygen for babies with fetal growth restriction (FGR), a condition where the baby is smaller than expected. If you are pregnant with one baby, between 24 and 34 weeks, and your baby is in the bottom 10% for weight, you may qualify.
Aurora, ColoradoAges 18–65 - NCT06803589RecruitingEarly Phase 1
Growth hormone for hard-to-treat stomach paralysis
This study tests if growth hormone can help people with long-term stomach paralysis (gastroparesis) that hasn't improved with standard care. It looks at whether the treatment reduces symptoms like nausea and feeling full too quickly.
Phoenix, ArizonaAges 18–65 - NCT06814353Enrolling by invitation
Studying where medulloblastoma starts in the brain
This trial observes where medulloblastoma tumors first appear and how they grow during surgery. It helps doctors better understand these rare childhood and adult brain tumors.
Vienna, State of ViennaAges Any age - NCT06709040Enrolling by invitation
Long-term safety of somapacitan in children with growth hormone deficiency
This study is watching children who are already taking somapacitan (a growth hormone injection) to see if it is safe over a long time. It collects information about growth and any side effects.
Glasgow, ScotlandAges Up to 18 years - NCT06694506Recruiting
Health outcomes in adults with childhood growth hormone deficiency
This study follows adults who had growth hormone deficiency as children and are now part of a research registry. It aims to understand their health outcomes as they transition into adulthood.
Brussels, Woluwe-saint-lambertAges 18 years+ - NCT06475521Enrolling by invitation
Study of a new infant formula for healthy babies
This study tests a new infant formula to see how healthy babies grow and develop. If your baby is healthy, full-term, and formula-fed, they may be able to join.
DupnitsaAges birth–2 weeks - NCT05746650Recruiting
Study to improve healing after knee muscle-tendon repair
This study looks at how to improve healing at the muscle-tendon connection after knee reconstruction surgery. You may be able to join if you’re otherwise healthy, within a certain body-size range, and not using medicines that could change muscle or tendon healing.
CopenhagenAges 18–35 - NCT06109935Enrolling by invitation
Long-term study of Sogroya for children with growth hormone deficiency
This trial is looking at how well Sogroya® (a growth hormone medicine) works when used for a long time in children with short stature caused by growth hormone deficiency. The goal is to see if it helps them grow taller safely.
AichiAges birth–18 years - NCT06018636Recruiting
Diet and nutrition in early childhood growth
This study looks at how diet and nutrition affect young children's growth and development. It may help you learn more about feeding your child well.
Swat, Khyber PakhtunkhwaAges 1 day–2 years - NCT05967689RecruitingPhase 2
Zipalertinib for lung cancer with EGFR exon 20 mutations
This Phase 2 trial tests zipalertinib (a targeted pill) in people with advanced non-small cell lung cancer (NSCLC) that has specific EGFR mutations, especially “exon 20 insertions.” It may help shrink tumors or slow cancer growth, including in some people with brain metastases.
Birmingham, AlabamaAges 18 years+ - NCT05868408Recruiting
Whey formula for healthy full-term infants – growth and comfort
This study tests whether a special partially-digested whey formula is as good as standard formula for healthy full-term babies. It looks at how babies grow and how well they tolerate the formula.
Cavite CityAges birth–4 weeks - NCT05796440Enrolling by invitationPhase 2
Long-term safety study of LUM-201 in children with growth hormone deficiency
This trial checks the long-term safety of LUM-201 in children who have idiopathic growth hormone deficiency and already completed an earlier LUM-201 study. If you previously took LUM-201 and are allowed to continue, the study may help your care team monitor ongoing effects over time.
Iowa City, IowaAges 5–14 - NCT05718570Enrolling by invitation
Long-term follow-up for adults taking Sogroya for growth hormone deficiency
This study follows adults with growth hormone deficiency who start (or have started) Sogroya to learn about its long-term safety. It does not change your treatment—it mainly checks for side effects and health outcomes over time.
Phoenix, ArizonaAges 18 years+
Hear when a new Growth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for growth?
- Yes. Clin2 currently lists 295 recruiting growth studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a growth trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a growth trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.